Jonathan Bernstein
5139314181 · Bernstein Clinical Research Center · University of Cincinnati
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Jonathan Bernstein as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 05:16 UTC. Open this list on ClinicalTrials.gov
- Ph4NCT06818474 · Lanadelumab in Long-term Prophylaxis of Acquired AngioedemaBernstein Clinical Research Center · recruiting · Angioedema · principal investigator
- Ph4NCT06690047 · Treatment of Hereditary Angioedema Prodrome with Recombinant C1-esterase Inhibitor (Ruconest)Bernstein Clinical Research Center · completed · Hereditary Angioedema · principal investigator
- Ph2NCT04530136 · Prevention of Severe SARS-CoV-2 Infection in Hospitalized Patients With COVID-19Pharming Technologies B.V. · completed · Confirmed Coronavirus Disease · principal investigator
- Ph4NCT04358224 · The Utility of Functionally Relevant Signature Genes in Assessing the Clinical Outcomes of Dupilumab TreatmentJonathan A. Bernstein, MD · completed · Atopic Dermatitis, Eczema · principal investigator
- N/ANCT02715375 · Investigate the Effect of the CREON2000A on Asthma Control in Children With Mild to Moderate Persistent AsthmaGeneral Innovations and Goods, Inc. · completed · Asthma · study chair
Grants
NIH projects from RePORTER, fetched 2026-11-12 05:16 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 4 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.
- Health Effects of CREON2000 in Asthmatic ChildrenU44AI074918 · NIAID · GENERAL INNOVATIONS AND GOODS, INC. · fiscal years 2014 to 2018 · $363,271 awarded in 2018Grant number is on one of their registry trials
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 05:16 UTC. The ranking covers the 200 most relevant of 171 PubMed records, and a shared surname and initials can bring in a namesake. All 171 on PubMed
- Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureus.N Engl J Med · 20061,162 citationsRCR 36.0
- Icatibant, a new bradykinin-receptor antagonist, in hereditary angioedema.N Engl J Med · 2010447 citationsRCR 13.8
- 381 citationsRCR 12.7
- 358 citationsRCR 9.7
- Efficacy of human C1 esterase inhibitor concentrate compared with placebo in acute hereditary angioedema attacks.J Allergy Clin Immunol · 2009286 citationsRCR 9.4
- Prognostic significance of the early course of minimal change nephrotic syndrome: report of the International Study of Kidney Disease in Children.J Am Soc Nephrol · 1997271 citationsRCR 8.6
- Dose to the contralateral breast from radiotherapy and risk of second primary breast cancer in the WECARE study.Int J Radiat Oncol Biol Phys · 2008261 citationsRCR 6.8
- Brief motivational intervention at a clinic visit reduces cocaine and heroin use.Drug Alcohol Depend · 2005254 citationsRCR 9.2
- 253 citationsRCR 10.8
- Screening and brief intervention for drug use in primary care: the ASPIRE randomized clinical trial.JAMA · 2014240 citationsRCR 11.7